Lothar H. Finke
Corporate Officer/Principal bij INCYTE CORPORATION
Actieve functies van Lothar H. Finke
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| INCYTE CORPORATION | Corporate Officer/Principal | 01-06-2017 | - |
Loopbaan van Lothar H. Finke
Eerdere bekende functies van Lothar H. Finke
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ARGOS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01-01-2004 | 01-02-2009 |
| MERCK KGAA | Corporate Officer/Principal | 01-11-1995 | 01-07-2004 |
| Basel Institute for Immunology | Corporate Officer/Principal | 01-01-1993 | 01-01-1994 |
Lexigen Pharmaceuticals Corp.
 Lexigen Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Lexigen Pharmaceuticals Corp. focuses on commercial physical and biological research. The company was founded by Stephen D. Gillies and is headquartered in Billerica, MA. | Corporate Officer/Principal | - | - |
EMD Pharmaceuticals, Inc.
 EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, EMD Pharmaceuticals, Inc. is a private company that manufactures pharmaceutical preparations. The company is based in Durham, NC. The company was founded by Nancy J. Wysenski. | Corporate Officer/Principal | - | - |
Opleiding van Lothar H. Finke
| Philipps University of Marburg | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| Duitsland | 3 |
| Zwitserland | 2 |
Operationeel
| Corporate Officer/Principal | 5 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| INCYTE CORPORATION | Health Technology |
| MERCK KGAA | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Argos Therapeutics, Inc.
 Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Argos Therapeutics, Inc. was a biopharmaceutical company. It engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. The firm's product include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Bruce A. Sullenger, Eli Gilboa, John A. Irick and Ralph M. Steinman on May 8, 1997 and was headquartered in Durham, NC. | Health Technology |
Lexigen Pharmaceuticals Corp.
Lexigen Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Lexigen Pharmaceuticals Corp. focuses on commercial physical and biological research. The company was founded by Stephen D. Gillies and is headquartered in Billerica, MA. | Commercial Services |
EMD Pharmaceuticals, Inc.
EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, EMD Pharmaceuticals, Inc. is a private company that manufactures pharmaceutical preparations. The company is based in Durham, NC. The company was founded by Nancy J. Wysenski. | Health Technology |
- Beurs
- Insiders
- Lothar H. Finke
- Ervaring
